Waverley Pharma Inc V.WAVE

Healthcare Biotechnology

Waverley Pharma Inc. is a biopharmaceutical company engaged in the research, development, and commercialization of human therapeutics focused on oncology. Its primary focus is the PARP-1 program and secondary focus is the generic oncology injectable market in European Union, the United Kingdom (UK) and North America. It has entered into a license, manufacture, supply, marketing and distribution agreement with Reliance Life Sciences Private Limited, which has granted it an exclusive territorial license to market and sell capecitabine in the UK and Germany as well as a non-exclusive territorial license to market and sell temozolomide and erlotinib in the UK. Its generic oncology products include bortezomib and pemetrexed. Bortezomib is an injectable generic chemotherapy drug, developed for the treatment of multiple myeloma and mantle cell lymphoma. Pemetrexed is an injectable generic chemotherapy drug, developed for the treatment of non-small cell lung cancer and pleural mesothelioma.

TSXV:WAVE - Post by User

Waverley Pharma Inc > Too many WAVE vendors back to 0.15 ¢ soon guarantee.........

<< Previous

Bullboard Posts

Next >>

Comment by Investingshaton Aug 24, 2020 1:58pm

143 Views

Post# 31446581

RE:Too many WAVE vendors back to 0.15 ¢ soon guarantee.........

I kno its a wish for you but will never come true only had 1.3 million shorts which is about 11% of the stocks that are out 75% is owned by the ceos so shorts have nothing to do here when it jumps it will jump over 2 to 3 hundred percent

<< Previous

Bullboard Posts

Next >>

BlackBerry partners with Avathon to enhance critical event management with AI